T1	Participants 76 97	HIV-infected subjects
T2	Participants 432 444	352 subjects
T3	Participants 1041 1059	placebo recipients
T4	Participants 982 990	two AIDS
T5	Participants 1159 1185	three AIDS-related complex
T6	Participants 1234 1258	18 in placebo recipients
T7	Participants 1357 1382	four AIDS or death events
T8	Participants 1419 1437	placebo recipients
T9	Participants 1454 1485	four ARC, AIDS, or death events
T10	Participants 1514 1550	two in placebo recipients (p = 0.79)
